Inventor · disambiguated record
Michael Kaleko
Also filed as: KALEKO MICHAEL
61 granted patents·26 pending applications·390 citations·filing 1995–2025
98Inventor score
Files withSYNTHETIC BIOLOGICS INC27THERIVA BIOLOGICS INC19NOVARTIS AG13SYNTHETIC BIOLOGIES INC4WELLSTAT IMMUNOTHERAPEUTICS LLC4
Top patents by PatentIndex Score
87 records- 0198US11608494B2Beta-lactamases with improved properties for therapyTHERIVA BIOLOGICS INC·Filed 2021·Granted Mar 21, 2023·2 cites·12 claims
- 0295US11236319B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2020·Granted Feb 1, 2022·2 cites·12 claims
- 0395US7202079B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Apr 10, 2007·22 cites·44 claims
- 0493US10767171B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2020·Granted Sep 8, 2020·2 cites·10 claims
- 0593US6864085B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2000·Granted Mar 8, 2005·24 cites·28 claims
- 0692US7442551B2Lentiviral packaging constructsNOVARTIS AG·Filed 2006·Granted Oct 28, 2008·16 cites·17 claims
- 0791US9744221B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Aug 29, 2017·3 cites·12 claims
- 0890US6608038B2Methods and compositions for treatment of diabetes and related conditions via gene therapyNOVARTIS AG·Filed 2001·Granted Aug 19, 2003·47 cites·8 claims
- 0989US5935935AAdenoviral vectors for treatment of hemophiliaGENETIC THERAPY INC·Filed 1995·Granted Aug 10, 1999·98 cites·65 claims
- 1088US7785877B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Aug 31, 2010·3 cites·26 claims
- 1188US7198793B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Apr 3, 2007·6 cites·21 claims
- 1288US7125712B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Oct 24, 2006·5 cites·56 claims
- 1388US7070993B2Lentiviral packaging constructsNOVARTIS AG·Filed 2002·Granted Jul 4, 2006·16 cites·24 claims
- 1488US2023313166A1Beta-lactamases with improved properties for therapyTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 1587US12274740B2Microbiome protection from oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·20 claims
- 1687US10987410B2Alkaline phosphatase formulationsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Apr 27, 2021·3 cites·6 claims
- 1787US10584326B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2019·Granted Mar 10, 2020·2 cites·18 claims
- 1887US10336995B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2018·Granted Jul 2, 2019·2 cites·12 claims
- 1987US7662621B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2006·Granted Feb 16, 2010·4 cites·49 claims
- 2087US2024197842A1Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 2186US11944669B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 2, 2024·0 cites·19 claims
- 2286US10087433B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 2, 2018·2 cites·18 claims
- 2386US10011824B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2017·Granted Jul 3, 2018·2 cites·31 claims
- 2486US9783797B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2017·Granted Oct 10, 2017·2 cites·32 claims
- 2586US9464280B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Oct 11, 2016·2 cites·25 claims
- 2686US9404103B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Aug 2, 2016·2 cites·29 claims
- 2785US10548955B2Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Feb 4, 2020·3 cites·14 claims
- 2885US9695409B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Jul 4, 2017·2 cites·35 claims
- 2985US9376673B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOG INC·Filed 2016·Granted Jun 28, 2016·2 cites·29 claims
- 3085US9290754B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOG INC·Filed 2015·Granted Mar 22, 2016·2 cites·19 claims
- 3185US7153512B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Dec 26, 2006·3 cites·17 claims
- 3284US7109029B2Vector constructsCELL GENESYS INC·Filed 2002·Granted Sep 19, 2006·29 cites·27 claims
- 3383US10046035B2Methods and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2017·Granted Aug 14, 2018·2 cites·12 claims
- 3483US7700342B2Lentiviral packaging constructsNOVARTIS AG·Filed 2006·Granted Apr 20, 2010·3 cites·8 claims
- 3582US12508304B2Alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·14 claims
- 3682US8236558B2Bovine immunodeficiency virus (BIV) based vectorsLUO TIANCI·Filed 2010·Granted Aug 7, 2012·3 cites·16 claims
- 3779US11883474B2Microbiome protection from oral antibioticsTHERIVA BIOLOGICS INC·Filed 2022·Granted Jan 30, 2024·0 cites·22 claims
- 3879US10415026B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 3979US6156497ARecombinase-mediated generation of adenoviral vectorsGENETIC THERAPY INC·Filed 1997·Granted Dec 5, 2000·45 cites·14 claims
- 4078US11981899B2E. coli-based production of beta-lactamaseTHERIVA BIOLOGICS INC·Filed 2022·Granted May 14, 2024·0 cites·7 claims
- 4178US9533028B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2015·Granted Jan 3, 2017·2 cites·17 claims
- 4276US11123413B2Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGIES INC·Filed 2019·Granted Sep 21, 2021·0 cites·14 claims
- 4376US9228003B2Complement factor B analogs and their usesCHEN CHANGHUNG·Filed 2012·Granted Jan 5, 2016·4 cites·15 claims
- 4475US11654184B2Alkaline phosphatase agents for treatment of radiation disordersTHERIVA BIOLOGICS INC·Filed 2019·Granted May 23, 2023·1 cites·15 claims
- 4574US11596674B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGIES INC·Filed 2020·Granted Mar 7, 2023·0 cites·19 claims
- 4674US2022000991A1Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 4773US10792346B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 6, 2020·0 cites·16 claims
- 4873US2023398194A1Methods and compositions for attenuating antibiotic resistanceTHERIVA BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 4972US12472147B2Intestinal alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2023·Granted Nov 18, 2025·0 cites·18 claims
- 5072US11542510B2E. coli-based production of beta-lactamaseSYNTHETIC BIOLOGICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·14 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Kaleko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →